The N-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy

Lisa E. Dorn, Lior Lasman, Jing Chen, Xianyao Xu, Thomas J. Hund, Mario Medvedovic, Jacob H. Hanna, Jop van Berlo, Federica Accornero

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

N-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. The role of m6A mRNA methylation in the heart is not known. Methods: To determine the role of m6A methylation in the heart, we isolated primary cardiomyocytes and performed m6A immunoprecipitation followed by RNA sequencing. We then generated genetic tools to modulate m6A levels in cardiomyocytes by manipulating the levels of the m6A RNA methylase methyltransferase-like 3 (METTL3) both in culture and in vivo. We generated cardiac-restricted gain- and loss-of-function mouse models to allow assessment of the METTL3-m6A pathway in cardiac homeostasis and function. Results: We measured the level of m6A methylation on cardiomyocyte mRNA, and found a significant increase in response to hypertrophic stimulation, suggesting a potential role for m6A methylation in the development of cardiomyocyte hypertrophy. Analysis of m6A methylation showed significant enrichment in genes that regulate kinases and intracellular signaling pathways. Inhibition of METTL3 completely abrogated the ability of cardiomyocytes to undergo hypertrophy when stimulated to grow, whereas increased expression of the m6A RNA methylase METTL3 was sufficient to promote cardiomyocyte hypertrophy both in vitro and in vivo. Finally, cardiac-specific METTL3 knockout mice exhibit morphological and functional signs of heart failure with aging and stress, showing the necessity of RNA methylation for the maintenance of cardiac homeostasis. Conclusions: Our study identified METTL3-mediated methylation of mRNA on N-adenosines as a dynamic modification that is enhanced in response to hypertrophic stimuli and is necessary for a normal hypertrophic response in cardiomyocytes. Enhanced m6A RNA methylation results in compensated cardiac hypertrophy, whereas diminished m6A drives eccentric cardiomyocyte remodeling and dysfunction, highlighting the critical importance of this novel stress-response mechanism in the heart for maintaining normal cardiac function.

Original languageEnglish (US)
Pages (from-to)533-545
Number of pages13
JournalCirculation
Volume139
Issue number4
DOIs
StatePublished - Jan 22 2019

Fingerprint

Methyltransferases
Cardiomegaly
Methylation
Cardiac Myocytes
Homeostasis
Messenger RNA
tRNA Methyltransferases
Hypertrophy
RNA
RNA Sequence Analysis
Immunoprecipitation
Knockout Mice
Adenosine
Phosphotransferases
Heart Failure
Maintenance

Keywords

  • RNA processing
  • gene expression profiling
  • hypertrophy
  • mice
  • post-transcriptional
  • transgenic

Cite this

Dorn, L. E., Lasman, L., Chen, J., Xu, X., Hund, T. J., Medvedovic, M., ... Accornero, F. (2019). The N-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy. Circulation, 139(4), 533-545. https://doi.org/10.1161/CIRCULATIONAHA.118.036146

The N-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy. / Dorn, Lisa E.; Lasman, Lior; Chen, Jing; Xu, Xianyao; Hund, Thomas J.; Medvedovic, Mario; Hanna, Jacob H.; van Berlo, Jop; Accornero, Federica.

In: Circulation, Vol. 139, No. 4, 22.01.2019, p. 533-545.

Research output: Contribution to journalArticle

Dorn, LE, Lasman, L, Chen, J, Xu, X, Hund, TJ, Medvedovic, M, Hanna, JH, van Berlo, J & Accornero, F 2019, 'The N-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy', Circulation, vol. 139, no. 4, pp. 533-545. https://doi.org/10.1161/CIRCULATIONAHA.118.036146
Dorn, Lisa E. ; Lasman, Lior ; Chen, Jing ; Xu, Xianyao ; Hund, Thomas J. ; Medvedovic, Mario ; Hanna, Jacob H. ; van Berlo, Jop ; Accornero, Federica. / The N-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy. In: Circulation. 2019 ; Vol. 139, No. 4. pp. 533-545.
@article{c5b168516ea642498d0ff9c5bd2e0698,
title = "The N-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy",
abstract = "N-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. The role of m6A mRNA methylation in the heart is not known. Methods: To determine the role of m6A methylation in the heart, we isolated primary cardiomyocytes and performed m6A immunoprecipitation followed by RNA sequencing. We then generated genetic tools to modulate m6A levels in cardiomyocytes by manipulating the levels of the m6A RNA methylase methyltransferase-like 3 (METTL3) both in culture and in vivo. We generated cardiac-restricted gain- and loss-of-function mouse models to allow assessment of the METTL3-m6A pathway in cardiac homeostasis and function. Results: We measured the level of m6A methylation on cardiomyocyte mRNA, and found a significant increase in response to hypertrophic stimulation, suggesting a potential role for m6A methylation in the development of cardiomyocyte hypertrophy. Analysis of m6A methylation showed significant enrichment in genes that regulate kinases and intracellular signaling pathways. Inhibition of METTL3 completely abrogated the ability of cardiomyocytes to undergo hypertrophy when stimulated to grow, whereas increased expression of the m6A RNA methylase METTL3 was sufficient to promote cardiomyocyte hypertrophy both in vitro and in vivo. Finally, cardiac-specific METTL3 knockout mice exhibit morphological and functional signs of heart failure with aging and stress, showing the necessity of RNA methylation for the maintenance of cardiac homeostasis. Conclusions: Our study identified METTL3-mediated methylation of mRNA on N-adenosines as a dynamic modification that is enhanced in response to hypertrophic stimuli and is necessary for a normal hypertrophic response in cardiomyocytes. Enhanced m6A RNA methylation results in compensated cardiac hypertrophy, whereas diminished m6A drives eccentric cardiomyocyte remodeling and dysfunction, highlighting the critical importance of this novel stress-response mechanism in the heart for maintaining normal cardiac function.",
keywords = "RNA processing, gene expression profiling, hypertrophy, mice, post-transcriptional, transgenic",
author = "Dorn, {Lisa E.} and Lior Lasman and Jing Chen and Xianyao Xu and Hund, {Thomas J.} and Mario Medvedovic and Hanna, {Jacob H.} and {van Berlo}, Jop and Federica Accornero",
year = "2019",
month = "1",
day = "22",
doi = "10.1161/CIRCULATIONAHA.118.036146",
language = "English (US)",
volume = "139",
pages = "533--545",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The N-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy

AU - Dorn, Lisa E.

AU - Lasman, Lior

AU - Chen, Jing

AU - Xu, Xianyao

AU - Hund, Thomas J.

AU - Medvedovic, Mario

AU - Hanna, Jacob H.

AU - van Berlo, Jop

AU - Accornero, Federica

PY - 2019/1/22

Y1 - 2019/1/22

N2 - N-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. The role of m6A mRNA methylation in the heart is not known. Methods: To determine the role of m6A methylation in the heart, we isolated primary cardiomyocytes and performed m6A immunoprecipitation followed by RNA sequencing. We then generated genetic tools to modulate m6A levels in cardiomyocytes by manipulating the levels of the m6A RNA methylase methyltransferase-like 3 (METTL3) both in culture and in vivo. We generated cardiac-restricted gain- and loss-of-function mouse models to allow assessment of the METTL3-m6A pathway in cardiac homeostasis and function. Results: We measured the level of m6A methylation on cardiomyocyte mRNA, and found a significant increase in response to hypertrophic stimulation, suggesting a potential role for m6A methylation in the development of cardiomyocyte hypertrophy. Analysis of m6A methylation showed significant enrichment in genes that regulate kinases and intracellular signaling pathways. Inhibition of METTL3 completely abrogated the ability of cardiomyocytes to undergo hypertrophy when stimulated to grow, whereas increased expression of the m6A RNA methylase METTL3 was sufficient to promote cardiomyocyte hypertrophy both in vitro and in vivo. Finally, cardiac-specific METTL3 knockout mice exhibit morphological and functional signs of heart failure with aging and stress, showing the necessity of RNA methylation for the maintenance of cardiac homeostasis. Conclusions: Our study identified METTL3-mediated methylation of mRNA on N-adenosines as a dynamic modification that is enhanced in response to hypertrophic stimuli and is necessary for a normal hypertrophic response in cardiomyocytes. Enhanced m6A RNA methylation results in compensated cardiac hypertrophy, whereas diminished m6A drives eccentric cardiomyocyte remodeling and dysfunction, highlighting the critical importance of this novel stress-response mechanism in the heart for maintaining normal cardiac function.

AB - N-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. The role of m6A mRNA methylation in the heart is not known. Methods: To determine the role of m6A methylation in the heart, we isolated primary cardiomyocytes and performed m6A immunoprecipitation followed by RNA sequencing. We then generated genetic tools to modulate m6A levels in cardiomyocytes by manipulating the levels of the m6A RNA methylase methyltransferase-like 3 (METTL3) both in culture and in vivo. We generated cardiac-restricted gain- and loss-of-function mouse models to allow assessment of the METTL3-m6A pathway in cardiac homeostasis and function. Results: We measured the level of m6A methylation on cardiomyocyte mRNA, and found a significant increase in response to hypertrophic stimulation, suggesting a potential role for m6A methylation in the development of cardiomyocyte hypertrophy. Analysis of m6A methylation showed significant enrichment in genes that regulate kinases and intracellular signaling pathways. Inhibition of METTL3 completely abrogated the ability of cardiomyocytes to undergo hypertrophy when stimulated to grow, whereas increased expression of the m6A RNA methylase METTL3 was sufficient to promote cardiomyocyte hypertrophy both in vitro and in vivo. Finally, cardiac-specific METTL3 knockout mice exhibit morphological and functional signs of heart failure with aging and stress, showing the necessity of RNA methylation for the maintenance of cardiac homeostasis. Conclusions: Our study identified METTL3-mediated methylation of mRNA on N-adenosines as a dynamic modification that is enhanced in response to hypertrophic stimuli and is necessary for a normal hypertrophic response in cardiomyocytes. Enhanced m6A RNA methylation results in compensated cardiac hypertrophy, whereas diminished m6A drives eccentric cardiomyocyte remodeling and dysfunction, highlighting the critical importance of this novel stress-response mechanism in the heart for maintaining normal cardiac function.

KW - RNA processing

KW - gene expression profiling

KW - hypertrophy

KW - mice

KW - post-transcriptional

KW - transgenic

UR - http://www.scopus.com/inward/record.url?scp=85060259454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060259454&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.118.036146

DO - 10.1161/CIRCULATIONAHA.118.036146

M3 - Article

C2 - 30586742

AN - SCOPUS:85060259454

VL - 139

SP - 533

EP - 545

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 4

ER -